March 12, 2025
The National Institute for Health and Care Excellence (NICE) has recommended cladribine (Mavenclad, Merck Serono) for adults in England with relapsing-remitting multiple sclerosis (RRMS). This decision makes […]
March 12, 2025
March 11, 2025 — The FDA has approved a new treatment for children with generalized myasthenia gravis (gMG), a disease that makes muscles weak and tired […]
March 11, 2025
TOPLINE: Rehabilitation delivered via a mobile-based video program — called teleneurorehabilitation — was as safe and effective as in-person rehabilitation in managing motor and nonmotor symptoms […]
March 11, 2025
The first migraine-specific tool to measure perceived external stigma reveals that patients worry most about misconceptions of secondary gains and minimization of their disease burden, new […]
March 10, 2025
The anti-seizure medication zonisamide significantly reduced the number of headache days per month in children with migraine, preliminary results of a retrospective study suggested. The data […]
March 10, 2025
Obstructive sleep apnea (OSA) may raise the risk for Parkinson’s disease (PD), but early use of continuous positive airway pressure (CPAP) may mediate that effect, a […]
March 10, 2025
A simple algorithm to aid in the selection of appropriate disease modifying therapies (DMTs) reduces racial disparities in patients with relapsing multiple sclerosis (MS), early new […]
March 7, 2025
WEST PALM BEACH, Fla. — New research testing the newly proposed McDonald Criteria showed that 32% more patients with a radiological-only presentation and 28% more with […]
March 7, 2025
TOPLINE: Poor retinal health in midlife was associated with significantly higher risk for Alzheimer’s disease and related dementias (ADRD) later in life, a new study showed. […]